Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity P Araos, M Pedraz, A Serrano, M Lucena, V Barrios, N Garcia-Marchena, ... Addiction Biology 20 (4), 756-772, 2015 | 106 | 2015 |
A place for the hippocampus in the cocaine addiction circuit: Potential roles for adult hippocampal neurogenesis E Castilla Ortega, A Serrano, E Blanco, P Araos, J Suarez, FJ Pavón, ... Neuroscience and Biobehavioral Reviews, 2016 | 95 | 2016 |
Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats D Silva Peña, N García Marchena, F Alén, P Araos, P Rivera, A Vargas, ... Addiction Biology 24 (5), 1019-1033, 2019 | 57 | 2019 |
Evaluation of plasma‐free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: Impact of psychiatric co‐morbidity FJ Pavón, P Araos, A Pastor, M Calado, M Pedraz, R Campos‐Cloute, ... Addiction biology 18 (6), 955-969, 2013 | 54 | 2013 |
Oleoylethanolamide dose‐dependently attenuates cocaine‐induced behaviours through a PPARα receptor‐independent mechanism A Bilbao, E Blanco, MJ Luque‐Rojas, J Suárez, A Palomino, M Vida, ... Addiction Biology 18 (1), 78-87, 2013 | 50 | 2013 |
Sex differences in psychiatric comorbidity and plasma biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in outpatient settings M Pedraz, P Araos, N Garcia-Marchena, A Serrano, P Romero-Sanchiz, ... FRONTIERS IN PSYCHIATRY 6, 2015 | 47 | 2015 |
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type … P Romero-Sanchiz, R Nogueira-Arjona, A Pastor, P Araos, A Serrano, ... Neuropharmacology 149, 212-220, 2019 | 44 | 2019 |
Plasma Concentrations of BDNF and IGF-1 in Abstinent Cocaine Users with High Prevalence of Substance Use Disorders: Relationship to Psychiatric Comorbidity M Pedraz, A Isabel Martin-Velasco, N Garcia-Marchena, P Araos, ... PLOS ONE 10 (3), 2015 | 40 | 2015 |
Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice MJ Luque-Rojas, P Galeano, J Suárez, P Araos, LJ Santín, ... International Journal of Neuropsychopharmacology 16 (3), 661-676, 2013 | 38 | 2013 |
Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders N Garcia-Marchena, D Silva-Pena, A Isabel Martin-Velasco, ... PLOS ONE 12 (11), 2017 | 36 | 2017 |
Comorbilidad psicopatológica en consumidores de cocaína en tratamiento ambulatorio P Araos, E Vergara-Moragues, M Pedraz, FJ Pavón, RC Cloute, M Calado, ... Adicciones 26 (1), 15-26, 2014 | 35 | 2014 |
Plasma chemokines in patients with alcohol use disorders: association of CCL11 (Eotaxin-1) with psychiatric comorbidity N García-Marchena, PF Araos, V Barrios, L Sánchez-Marín, JA Chowen, ... Frontiers in psychiatry 7, 214, 2017 | 32 | 2017 |
Lipid transmitter signaling as a new target for treatment of cocaine addiction: new roles for acylethanolamides and lysophosphatidic acid L Orio, F Javier Pavon, E Blanco, A Serrano, P Araos, M Pedraz, P Rivera, ... Current pharmaceutical design 19 (40), 7036-7049, 2013 | 30 | 2013 |
Higher impulsivity as a distinctive trait of severe cocaine addiction among individuals treated for cocaine or alcohol use disorders N García-Marchena, D Ladrón de Guevara-Miranda, M Pedraz, PF Araos, ... Frontiers in Psychiatry 9, 26, 2018 | 29 | 2018 |
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence N Garcia-Marchena, FJ Pavon, A Pastor, P Araos, M Pedraz, ... Addiction Biology 22 (5), 1366-1377, 2017 | 28 | 2017 |
Cocaine-induced psychotic symptoms in clinical setting E Vergara-Moragues, PA Gómez, F González-Saiz, F Rodríguez-Fonseca Psychiatry research 217 (1-2), 115-120, 2014 | 28 | 2014 |
Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGF alpha) as a potential biomarker of … R Maza-Quiroga, N Garcia-Marchena, P Romero-Sanchiz, V Barrios, ... PEERJ 5, 2017 | 26 | 2017 |
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders N Garcia-Marchena, M Barrera, J Ignasi Mestre-Pinto, P Araos, A Serrano, ... PLOS ONE 14 (3), 2019 | 25 | 2019 |
Psychiatric comorbidity and plasma levels of 2-acyl-glycerols in outpatient treatment alcohol users. Analysis of gender differences N García-Marchena, P Araos, FJ Pavón, G Ponce, M Pedraz, A Serrano, ... Adicciones 29 (2), 83-96, 2016 | 23 | 2016 |
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder N Requena-Ocaña, P Araos, M Flores, N García-Marchena, D Silva-Peña, ... Scientific Reports 11 (1), 15583, 2021 | 22 | 2021 |